Anzeige
Mehr »
Login
Samstag, 11.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

AFX News-Archiv vom 30.05.2020

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
30.05.20Pier 1 Imports Receives U.S. Court Approval To Liquidate Stores1.014WASHINGTON (dpa-AFX) - Struggling home furnishings retailer Pier 1 Imports Inc. said that it received approval from the U.S. Bankruptcy Court for the Eastern District of Virginia for the company's...
► Artikel lesen
30.05.20Lufthansa Executive Board Accepts Germany's EUR 9 Bln Rescue Package1.388COLOGNE (dpa-AFX) - Deutsche Lufthansa AG's (DLAKF, DLAKY) executive board has accepted the German Government's 9 billion euros rescue package, due to the European Union reduced its conditions...
► Artikel lesen
30.05.20The Week That Was: Merck & Co. Enters COVID Space, GSK's 1Bln Dose Target, Roche, GILD Team Up For REMDACTA1.885FOSTER CITY (dpa-AFX) - The safety of malaria drug Hydroxychloroquine, which was touted by President Trump as a 'game-changer' in the fight against coronavirus, has been called into question...
► Artikel lesen
30.05.20Pliant Therapeutics To Debut On Nasdaq On June 31.291BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - South San Francisco, California-based Pliant Therapeutics is slated to debut on the Nasdaq Global Market, under the symbol 'PLRX', on June 3, 2020.Founded...
► Artikel lesen
30.05.20FDA Oks AbbVie's Oriahnn To Treat Heavy Menstrual Bleeding Associated With Fibroids In Women1.191WASHINGTON (dpa-AFX) - AbbVie (ABBV), in cooperation with Neurocrine Biosciences Inc. (NBIX), said that the U.S. Food and Drug Administration approved Oriahnn capsules, co-packaged for oral...
► Artikel lesen
30.05.20Pfizer Says Breast Cancer Trial Unlikely To Be Effective1.375NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) said that its Phase 3 early breast cancer PALbociclib CoLlaborative Adjuvant trial is unlikely to show a statistically significant improvement in...
► Artikel lesen
30.05.20AT&T: CWA-Represented Employees Approve West Wireline Agreement1.108DALLAS (dpa-AFX) - Leadership of Communications Workers of America District 9 has notified AT&T that CWA-represented employees have voted to ratify the West wireline agreement.The company...
► Artikel lesen
30.05.20FDA Approves Lilly's Cyramza To Treat Metastatic EGFR-Mutated Non-Small Cell Lung Cancer1.026INDIANAPOLIS (dpa-AFX) - Eli Lilly and Co. (LLY) said that the U.S. Food and Drug Administration has approved Cyramza, in combination with erlotinib, for the first-line treatment of people...
► Artikel lesen